Cargando…

Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years

We report three cases of nonmetastatic prostate cancer treated effectively with long‐term primary intermittent androgen deprivation (IAD). IAD is not a standard therapy for patients with nonmetastatic prostate cancer. However, based on our experience, we suggest that IAD is one of useful therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Shida, Yohei, Hakariya, Tomoaki, Miyata, Yasuyoshi, Sakai, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378862/
https://www.ncbi.nlm.nih.gov/pubmed/28396761
http://dx.doi.org/10.1002/ccr3.854
_version_ 1782519495226556416
author Shida, Yohei
Hakariya, Tomoaki
Miyata, Yasuyoshi
Sakai, Hideki
author_facet Shida, Yohei
Hakariya, Tomoaki
Miyata, Yasuyoshi
Sakai, Hideki
author_sort Shida, Yohei
collection PubMed
description We report three cases of nonmetastatic prostate cancer treated effectively with long‐term primary intermittent androgen deprivation (IAD). IAD is not a standard therapy for patients with nonmetastatic prostate cancer. However, based on our experience, we suggest that IAD is one of useful therapeutic tools under certain patients’ condition.
format Online
Article
Text
id pubmed-5378862
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-53788622017-04-10 Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years Shida, Yohei Hakariya, Tomoaki Miyata, Yasuyoshi Sakai, Hideki Clin Case Rep Case Reports We report three cases of nonmetastatic prostate cancer treated effectively with long‐term primary intermittent androgen deprivation (IAD). IAD is not a standard therapy for patients with nonmetastatic prostate cancer. However, based on our experience, we suggest that IAD is one of useful therapeutic tools under certain patients’ condition. John Wiley and Sons Inc. 2017-02-23 /pmc/articles/PMC5378862/ /pubmed/28396761 http://dx.doi.org/10.1002/ccr3.854 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Shida, Yohei
Hakariya, Tomoaki
Miyata, Yasuyoshi
Sakai, Hideki
Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years
title Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years
title_full Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years
title_fullStr Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years
title_full_unstemmed Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years
title_short Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years
title_sort three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378862/
https://www.ncbi.nlm.nih.gov/pubmed/28396761
http://dx.doi.org/10.1002/ccr3.854
work_keys_str_mv AT shidayohei threecasesofnonmetastaticprostatecancertreatedsuccessfullywithprimaryintermittentandrogendeprivationtherapyover10years
AT hakariyatomoaki threecasesofnonmetastaticprostatecancertreatedsuccessfullywithprimaryintermittentandrogendeprivationtherapyover10years
AT miyatayasuyoshi threecasesofnonmetastaticprostatecancertreatedsuccessfullywithprimaryintermittentandrogendeprivationtherapyover10years
AT sakaihideki threecasesofnonmetastaticprostatecancertreatedsuccessfullywithprimaryintermittentandrogendeprivationtherapyover10years